Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05046184

Organisation Name: University of Texas Southwestern Medical Center

Overal Status: Not yet recruiting

Start Date: November 1, 2021

Last Update: September 16, 2021

Lead Sponsor: University of Texas Southwestern Medical Center

Brief Summary: The study is investigating dysfunctions in neurocircuitry in regards to irritability with healthy controls (HC) and individuals with Major Depressive Disorder (MDD) by performing MRIs. The MDD group will also be randomized to receive ketamine or midazolam to investigate changes post-treatment in neurocircuitry with regards to irritability.

Conditions:
  • Major Depressive Disorder
  • Healthy Controls


Total execution time in seconds: 0.17809009552002